Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.62 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.41 |
| ▸ | CCKAR | P32238 | 7/20 | 0.41 |
| ▸ | CCKBR | P32239 | 7/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12424093 | 1.00 | GLP1R (0.62) | GLP1RNOD1CCKARCCKBRFOLH1 | |
| SCHEMBL22627089 | 0.94 | GLP1R (0.56) | GLP1RNOD1CCKARCCKBRFOLH1 | |
| SCHEMBL21172447 | 0.90 | GLP1R (0.58) | GLP1RNOD1CCKARCCKBR | |
| SCHEMBL24179869 | 0.88 | GLP1R (0.60) | GLP1RNOD1CCKARCCKBR | |
| SCHEMBL21172278 | 0.88 | GLP1R (0.58) | GLP1RNOD1CCKARCCKBR | |
| SCHEMBL12519878 | 0.87 | GLP1R (0.73) | GLP1RNOD1CCKARCCKBRFOLH1 | |
| SCHEMBL17401159 | 0.86 | GLP1R (0.64) | GLP1RNOD1CCKARCCKBRFOLH1 | |
| SCHEMBL21172239 | 0.86 | GLP1R (0.63) | GLP1RNOD1CCKARCCKBRFOLH1 | |
| SCHEMBL12518540 | 0.84 | GLP1R (0.60) | GLP1RNOD1CCKARCCKBRFOLH1 | |
| SCHEMBL19271257 | 0.84 | GLP1R (0.61) | GLP1RCCKARCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011089255-A1 | GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY | NOVO NORDISK HEALTH CARE AG (CH) | 2011-07-28 | — | — | WO | disclosed |